Maverick Minerals Australia (ASX:M96) has completed its A$2.7m acquisition of the Viper Project in the WA1 Resources-anchored West Arunta region.
Rare Earths Stocks
ABx Group (ASX:ABX) says its ALCORE process can produce hydrogen fluoride at US$1,000-1,600/t, implying 30-60% operating margins against acidspar competitors.
IperionX (ASX:IPX) has completed the Camden acquisition, with stockpile assays hitting 23% THM, 10x the Titan Project’s average grade.
Lindian Resources (ASX:LIN) fires the first blast at Kangankunde, moving from developer to producer as Q4 2026 first production nears.
Fortuna Metals (ASX:FUN) has produced a 96.66% TiO2 rutile product from its Mkanda bulk sample, beating the Kasiya benchmark next door.
Iluka Resources (ASX:ILU) signs an 18-year rare earth concentrate deal with VHM plus a A$40m convertible note, deepening Eneabba’s feedstock security.
IperionX (ASX:IPX) has completed the Camden acquisition, with stockpile assays hitting 23% THM, 10x the Titan Project’s average grade.
Today is the first day of the new financial year, and we think plenty of investors are wondering which ASX Stocks to Buy in FY27. Stocks Down Under recaps 10 stocks that it thinks is set for a good 12 months ahead.
10 ASX Stocks to Buy in FY27
Goodman Group (ASX:GMG)
Goodman enters FY27 with…
Brazilian Critical Minerals (ASX:BCM) delivers Ema BFS with a US$1.47B post-tax NPV, 105% IRR and US$74M capex, repositioning the project for financing.
Temas Resources (ASX:TIO) re-assays of historic La Blache core deliver 143m at 88.7% Fe-Ti plus gallium, scandium and chromium credits.
